Oklo delivered the milestone that mattered most last quarter, bringing its Groves reactor to first criticality on the schedule management had repeated for nearly a year. The market's response has been brutal anyway. Shares have fallen almost 39% since that report while the S&P 500 barely moved, leaving the stock at $27.12, less than half its 200-day moving average of $54.80 and only modestly above the $25.39 low of its post-earnings range. That disconnect sets up the third-quarter report, due before the open on November 6, as a test of whether proven execution can matter more than a rapidly rising spending bill.

The headline numbers will not settle that debate. Consensus calls for a loss of 28 cents a share, matching last quarter's loss and wider than the 20-cent loss a year ago. That is a 40% deterioration in per-share results, which is the predictable cost of building first-of-a-kind reactors. The earnings whisper sits lower at a 33-cent loss, a meaningful gap for a company this size, suggesting the more engaged crowd expects first-of-a-kind Idaho costs to show up faster on the income statement. Revenue is expected at about $2.2 million, up from $1.2 million last quarter. That is real sequential growth, but it is small enough to be beside the point for valuation.

What matters is the spending trajectory management laid out last time. Oklo raised its 2026 operating cash-use outlook to $120 million to $150 million from $80 million to $100 million. It also lifted capital spending guidance to $400 million to $500 million from $350 million to $450 million. Management presented this as a deliberate choice to pull forward procurement, grid interconnection and fuel work to protect the 2028 Aurora startup at Idaho National Laboratory. With roughly $3.0 billion in cash and marketable securities, the balance sheet can absorb it. The validating outcome is spending that tracks inside those ranges alongside visible progress on the items it was meant to accelerate. A second upward revision without matching milestones would recast the raise as cost creep rather than conviction.

The largest unanswered question is cost. Management has deferred a full Aurora INL cost figure, including capital cost per megawatt, across three straight calls, each time pointing to later in 2026. With the year nearly over, this report is the natural place to deliver it. A credible number would give investors something to underwrite. Another postponement would sharpen the suspicion that the economics are still unsettled, and that may already explain part of the selloff.

Commercial conversion is the other test. Oklo's customer relationships, including Meta and Equinix, still rest on letters of intent and prepayment structures rather than binding power purchase agreements. Even one firm contract would strengthen the narrative. Fuel deserves attention too: the Centris letter of intent covering up to five powerhouses, advanced negotiations with the Department of Energy over roughly 20 tons of surplus plutonium, and A3F fabrication equipment slated for 2027 installation. Watch also for any further slippage in isotope revenue, which has already moved into early 2027. Progress on the Kiewit partnership for Ohio and on PJM interconnection timing would help, as would early contributions from the Armec and Creative Engineers acquisitions.

Sentiment has drifted from essentially neutral to modestly bearish, consistent with a stock that has been repriced hard despite better operating news. That lowers the bar in one sense, but the market is clearly no longer paying for milestones alone. The narrative stays intact if Oklo can show that its accelerated spending buys schedule certainty and pair it with a hard cost figure or a binding offtake. Without either, criticality risks becoming a celebrated achievement that the stock has already moved past.